Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Highlights
Nov 03, 2016 11:01 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the third quarter ended September 30, 2016. Loss from operations for the three months ended...
Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Highlights
Nov 03, 2016 11:01 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the third quarter ended September 30, 2016. Loss from operations for the three months ended...
Nov 03, 2016 11:01 am UTC| Business
Book Value Per Common Share(2) of $15.30, Up 18.5% Since September30, 2015Annualized Return on Common Equity of 15.9% and Annualized Operating Return on Common Equity(1) of 19.4% Financial Highlights Third...
Nov 03, 2016 11:01 am UTC| Business
Book Value Per Common Share(2) of $15.30, Up 18.5% Since September30, 2015Annualized Return on Common Equity of 15.9% and Annualized Operating Return on Common Equity(1) of 19.4% Financial Highlights Third...
Nov 03, 2016 11:01 am UTC| Business
SARASOTA, Fla., Nov. 03, 2016 -- UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. (OTCQB:UNIR) (“Uniroyal Global Engineered Products, Inc.” or the Company) will report its earnings for the three months ended October 2, 2016 on...
Nov 03, 2016 11:01 am UTC| Business
SARASOTA, Fla., Nov. 03, 2016 -- UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC. (OTCQB:UNIR) (“Uniroyal Global Engineered Products, Inc.” or the Company) will report its earnings for the three months ended October 2, 2016 on...
Nov 03, 2016 11:01 am UTC| Business
EL SEGUNDO, Calif., Nov. 03, 2016 -- Landmark Infrastructure Partners LP (the “Partnership,” “we,” “us” or “our”) (Nasdaq:LMRK) today announced its third quarter 2016 financial results. Highlights Announced a...